Last mentioned: Mar 6, 2026
Potential Extension
Aptorum may apply for a second 180-day period if compliance is not met but criteria are satisfied.
Initial Compliance Deadline
End of the first 180-day grace period to regain a $1.00 closing bid price.
Deficiency Notice Received
Nasdaq notifies Aptorum of non-compliance with the $1.00 minimum bid price rule.
Aptorum and DeFi Technologies have received formal deficiency notices from Nasdaq for failing to maintain the $1.00 minimum bid price requirement. Both companies now face a 180-day deadline to regain compliance or risk being delisted to the over-the-counter markets.
Aptorum Group Limited (APM) has received a formal deficiency notice from Nasdaq for failing to maintain the $1.00 minimum bid price required for continued listing. The company now enters a critical 180-day window to regain compliance, highlighting the ongoing financial pressures facing small-cap clinical-stage biotech firms.